Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Type of Wound;
By Grade (Grade 0, Grade 1, Grade 2, Grade 3, Grade 4, and Grade 6) and By Stage (Stage 1, Stage 2, Stage 3, and Stage 4).By Treatment;
Wound Care Dressings (Surgical Debridement, Foam Dressings, Film Dressings, Hydrocolloid Dressings, Alginate Dressings, and Hydrogel Dressings), Bio-actives (Skin Grafts & Substitutes, Growth Factors, and Others) and Therapy Wound Care Devices (Negative Pressure Wound Therapy, Ultrasound Therapy, and Others).By End Users;
Hospital Inpatient Settings, Hospital Outpatient Settings, Community Health Centers, Home Healthcare, and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market (USD Million), 2021 - 2031
In the year 2024, the Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market was valued at USD 11,392.97 million. The size of this market is expected to increase to USD 18,876.89 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.5%.
The Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market addresses a critical aspect of healthcare, focusing on the management and treatment of two prevalent and often debilitating conditions: diabetic foot ulcers and pressure ulcers. Diabetic foot ulcers are a common complication of diabetes, resulting from poor circulation and nerve damage, while pressure ulcers, also known as bedsores, occur due to prolonged pressure on the skin.
This market encompasses a range of products and therapies designed to prevent, diagnose, and treat diabetic foot ulcers and pressure ulcers, aiming to improve patient outcomes and quality of life. From advanced wound dressings and topical treatments to surgical interventions and specialized footwear, the market offers diverse solutions tailored to the specific needs of patients with these conditions.
As the prevalence of diabetes and chronic conditions continues to rise globally, the incidence of diabetic foot ulcers and pressure ulcers is also increasing, driving demand for effective treatment options. Healthcare providers and policymakers recognize the importance of proactive management and early intervention to prevent complications and reduce the economic burden associated with these conditions.
In this dynamic and evolving landscape, innovation plays a crucial role in driving advancements in treatment modalities and improving patient care. Manufacturers and researchers are continually developing new technologies, such as bioactive wound dressings, negative pressure wound therapy, and regenerative medicine approaches, to address the complex challenges posed by diabetic foot ulcers and pressure ulcers.
Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market Recent Developments
-
In April 2024, Smith+Nephew announced that the U.K. National Institute for Health and Care Excellence (NICE) conducted a review of the PICO Single Use Negative Pressure Wound Therapy System (sNPWT). NICE concluded that the system offers improved clinical outcomes compared to standard dressings in reducing the risk of surgical site infections.
-
In August 2022, 3M launched the new 3M Veraflo Cleanse Choice Complete Dressing Kit along with a software upgrade for the 3M V.A.C. Ulta Therapy Unit, aimed at enhancing the delivery of Veraflo therapy for patients.
Segment Analysis
This report extensively covers different segments of Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
The market encompasses a wide range of products and therapies designed to manage and treat diabetic foot ulcers and pressure ulcers, two conditions that pose significant health risks for affected individuals. The market is segmented by Type of Wound, Treatment, End Users, and Geography, offering a comprehensive view of the various factors shaping this sector.
In terms of Type of Wound, the market is segmented into By Grade (Grade 0, Grade 1, Grade 2, Grade 3, Grade 4, and Grade 6) and By Stage (Stage 1, Stage 2, Stage 3, and Stage 4). By Treatment, the market includes various therapeutic options such as wound dressings, debridement, negative pressure wound therapy, growth factors, skin grafts, and hyperbaric oxygen therapy, among others. These treatments aim to accelerate the healing process, prevent infection, and promote tissue regeneration.
The End Users segment encompasses healthcare providers such as hospitals, clinics, and specialized wound care centers, as well as home care settings. This segmentation reflects the diverse environments in which patients receive care and the tailored approaches required to address their specific needs. Geographically, the market is segmented into five regions: North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. Each region presents unique opportunities and challenges in terms of market growth, influenced by factors such as the prevalence of diabetes, the availability of healthcare infrastructure, and patient awareness.
Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Segment Analysis
In this report, the Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market has been segmented by Type of Wound, Treatment, End Users, and Geography.
Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market, Segmentation by Type of Wound
The Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market has been segmented by Type of Wound into By Grade (Grade 0, Grade 1, Grade 2, Grade 3, Grade 4, and Grade 6) and By Stage (Stage 1, Stage 2, Stage 3, and Stage 4).
By Grade refers to the severity of diabetic foot ulcers, which are classified using the Wagner Ulcer Classification System. This system ranges from Grade 0 to Grade 5, with each grade indicating the progression of the ulcer. Grade 0 represents no open ulceration but may include deformities or pre-ulcerative conditions. Grade 1 refers to superficial ulceration without penetration to deeper tissues. Grade 2 encompasses full-thickness ulcers that may reach tendons, bones, or other tissues. Grade 3 includes ulcers with infection, abscess, or osteomyelitis. Grade 4 represents partial gangrene, while Grade 5 indicates extensive gangrene requiring immediate medical intervention.
By Stage refers to the severity of pressure ulcers, which are classified according to the National Pressure Injury Advisory Panel (NPIAP). Stage 1 pressure ulcers are characterized by non-blanchable erythema of intact skin, indicating early damage. Stage 2 ulcers involve partial-thickness skin loss with exposed dermis, presenting as a shallow open ulcer or blister. Stage 3 ulcers are characterized by full-thickness skin loss, where the wound extends to the subcutaneous tissue but not to underlying muscle or bone. Stage 4 ulcers involve full-thickness skin and tissue loss, with potential exposure of muscle, bone, or other supporting structures.
Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market, Segmentation by Treatment
The Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market has been segmented by Treatment into Wound Care Dressings (Surgical Debridement, Foam Dressings, Film Dressings, Hydrocolloid Dressings, Alginate Dressings, and Hydrogel Dressings), Bio-actives (Skin Grafts & Substitutes, Growth Factors, and Others) and Therapy Wound Care Devices (Negative Pressure Wound Therapy, Ultrasound Therapy, and Others).
Wound care dressings play a crucial role in the healing process by providing a protective barrier over the wound, promoting a moist healing environment, and managing exudate. Surgical debridement is a process that removes dead or infected tissue from the wound to promote healing. Foam dressings offer excellent absorption capabilities and provide cushioning and protection for the wound. Film dressings are thin and transparent, allowing the wound to be monitored without removal and offering a barrier against external contaminants. Hydrocolloid dressings are moisture-retentive and promote autolytic debridement. Alginate dressings are derived from seaweed and are known for their high absorbency, making them suitable for wounds with heavy exudate. Hydrogel dressings provide moisture to dry wounds and help to debride necrotic tissue.
Bio-actives represent advanced treatment options that support the wound healing process at the cellular level. Skin grafts and substitutes are used to replace damaged or lost tissue, promoting tissue regeneration and healing. Growth factors are biologically active proteins that stimulate cell proliferation and tissue repair, accelerating the healing process. Other bio-actives may include topical agents that promote healing or infection control.
Therapy wound care devices encompass a range of advanced technologies designed to optimize the wound healing process. Negative pressure wound therapy (NPWT) involves the application of controlled negative pressure to the wound, which helps to remove exudate, reduce edema, and promote the formation of granulation tissue. Ultrasound therapy uses sound waves to stimulate healing by increasing blood flow and promoting cell regeneration. Other wound care devices may include electrical stimulation, laser therapy, and other emerging technologies designed to improve healing outcomes.
Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market , Segmentation by End Users
The Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market has been segmented by End Users into Hospital Inpatient Settings, Hospital Outpatient Settings, Community Health Centers, Home Healthcare, and Others.
Hospital inpatient settings offer a comprehensive level of care for patients with severe or complex wounds that require close monitoring and intensive treatment. Patients admitted to the hospital receive round-the-clock medical attention, with access to advanced wound care technologies, specialized wound care teams, and the possibility of surgical interventions when necessary.
Hospital outpatient settings provide care for patients who do not require hospitalization but still benefit from regular medical supervision and treatment. Outpatient services may include routine wound assessments, debridement, dressing changes, and other interventions as needed. Community health centers play a vital role in offering accessible and cost-effective care to patients within their local communities. These centers provide wound care services, including dressing changes and patient education, and help manage patients' ongoing care plans.
Home healthcare allows patients to receive treatment in the comfort of their own homes. This setting is particularly beneficial for patients with mobility challenges or those who prefer to recover in a familiar environment. Home healthcare providers offer a range of services, including wound assessments, dressing changes, and patient education on self-care. Other specialized facilities, such as wound care centers or long-term care facilities, may provide dedicated wound care services for patients with chronic or complex wounds. These facilities offer specialized care plans and advanced treatments tailored to the specific needs of each patient.
Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market, Segmentation by Geography
In this report, the Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market Share (%), by Geographical Region, 2024
North America dominates the market due to the high prevalence of diabetes and related complications, as well as advanced healthcare infrastructure and access to innovative treatments. This region is also characterized by strong research and development activities, resulting in new and effective treatment options for diabetic foot ulcers and pressure ulcers.
Europe holds a significant share in the market due to an aging population, a high incidence of diabetes, and a well-established healthcare system. The region is also home to leading medical technology companies, which contribute to the availability of advanced wound care products and therapies.
The Asia Pacific region is expected to experience substantial growth in the diabetic foot ulcers and pressure ulcers treatment market due to the rising prevalence of diabetes and related complications in countries like China and India. Increasing awareness of advanced wound care treatments and improving healthcare infrastructure further contribute to market growth in the region.
The Middle East and Africa region faces challenges such as limited access to healthcare services and lower awareness of wound care treatments. The region is gradually improving its healthcare infrastructure, which may lead to growth opportunities in the future. Governments and international organizations are investing in initiatives to enhance medical services and awareness in these regions.
Latin America is another region with potential for market growth, driven by an increase in diabetes cases and a growing aging population. The region's market may benefit from the adoption of advanced wound care treatments and an increasing focus on healthcare improvements.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market. These factors include; Market Drivers, Restraints, and Opportunities Analysis.
Drivers, Restraints, and Opportunities Analysis.
Drivers:
- Increasing Prevalence of Diabetes
- Aging Population
- Growing Healthcare Expenditure
- Government Support
-
Rising Awareness - Rising awareness about the complications and management of diabetic foot ulcers and pressure ulcers is driving demand for treatments in the global market. As more information becomes available about the risks associated with untreated or poorly managed ulcers, patients and healthcare providers are prioritizing early diagnosis and intervention. Educational campaigns and outreach programs highlight the importance of maintaining good foot hygiene and regular screenings for those at risk, particularly diabetic patients and the elderly.
Healthcare organizations and advocacy groups play a key role in raising awareness through workshops, seminars, and online resources, which provide valuable knowledge about the latest treatment options and preventive measures. Increased awareness also prompts patients to seek medical attention earlier in the progression of an ulcer, potentially improving outcomes and reducing complications.
As awareness grows, patients are becoming more informed consumers, seeking out advanced wound care products and therapies to manage their conditions effectively. This shift in patient expectations drives innovation and encourages companies to invest in developing more advanced and efficient treatment options. Rising awareness is contributing to a more proactive approach to managing diabetic foot ulcers and pressure ulcers, benefiting both patients and the healthcare industry.
Restraints:
- Limited Access to Healthcare
- Regulatory Hurdles
- Risk of Infections
- Variability in Treatment Guideline
-
Limited Reimbursement - Limited reimbursement for treatments of diabetic foot ulcers and pressure ulcers poses a significant restraint on the global market. Healthcare systems often struggle to cover the costs associated with advanced wound care, particularly in lower-income countries or regions where health insurance systems are underdeveloped. Even in developed countries, reimbursement policies may not adequately cover newer or more innovative treatments, creating financial barriers for patients and healthcare providers.
This limitation can hinder access to optimal care for patients, as healthcare providers may be less likely to recommend expensive treatments that are not fully reimbursed. In some cases, patients may opt for cheaper, less effective treatment options due to cost concerns. This can lead to suboptimal outcomes and increased long-term healthcare costs as patients require more extensive care over time.
Limited reimbursement can stifle innovation in the market, as companies may be less inclined to invest in research and development for new therapies if there is uncertainty about reimbursement policies. Without sufficient financial support, healthcare providers may find it challenging to offer the latest treatments, affecting the overall quality of care provided to patients with diabetic foot ulcers and pressure ulcers.
Opportunities:
- Development of Novel Treatments
- Growth in Home Healthcare
- Telemedicine and Remote Monitoring
- Partnerships and Collaborations
- Targeted Therapies
-
Education and Training - Education and training present significant opportunities in the global diabetic foot ulcers and pressure ulcers treatment market. By providing targeted education and training programs, healthcare professionals, caregivers, and patients can gain a better understanding of the best practices for managing and preventing these conditions. This knowledge can lead to improved patient outcomes, greater adherence to treatment plans, and reduced complications.
For healthcare professionals, specialized training in advanced wound care techniques and new treatment modalities enables them to provide high-quality care to patients with diabetic foot ulcers and pressure ulcers. Continued education helps clinicians stay current with the latest advancements in wound management, enabling them to offer the most effective and up-to-date treatments.
For patients and caregivers, educational programs can provide crucial information on preventive measures, such as proper foot care, regular inspections, and early recognition of warning signs. Empowering patients and caregivers with this knowledge can lead to more proactive approaches in managing the conditions and seeking timely medical attention.
Competitive Landscape Analysis
Key players in Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market include,
- ConvaTec Group PLC
- Essity Aktiebolag AB
- ORGANOGENESIS HOLDINGS INC.
- Molnlycke Health Care AB
- Integra LifeSciences Holdings Corporation
- Smith and Nephew PLC.
- 3M Company
- B. Braun SE
- Cardinal Health Inc.
- Coloplast
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type of Wound
- Market Snapshot, By Treatment
- Market Snapshot, By End Users
- Market Snapshot, By Region
- Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing Prevalence of Diabetes
- Aging Population
- Growing Healthcare Expenditure
- Government Support
- Rising Awareness
- Restraints
- Limited Access to Healthcare
- Regulatory Hurdles
- Risk of Infections
- Variability in Treatment Guideline
- Limited Reimbursement
- Opportunities
- Development of Novel Treatments
- Growth in Home Healthcare
- Telemedicine and Remote Monitoring
- Partnerships and Collaborations
- Targeted Therapies
- Education and Training
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market, By Type of Wound, 2021 - 2031 (USD Million)
- By Grade
- Grade 0
- Grade 1
- Grade 2
- Grade 3
- Grade 4
- Grade 6
- By Stage
- Stage 4
- Stage 3
- Stage 2
- Stage 1
- By Grade
- Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market, By Treatment, 2021 - 2031 (USD Million)
- Wound Care Dressings
- Surgical Debridement
- Foam Dressings
- Film Dressings
- Hydrocolloid Dressings
- Alginate Dressings
- Hydrogel Dressings
- Bio-actives
- Others
- Growth Factors
- Skin Grafts & Substitutes
- Therapy wound Care Devices
- Negative Pressure Wound Therapy
- Ultrasound Therapy
- Others
- Wound Care Dressings
- Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market, By End Users, 2021 - 2031 (USD Million)
- Hospital Inpatient Settings
- Hospital Outpatient Settings
- Community Health Centers
- Home Healthcare
- Others
- Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Diabetic Foot Ulcers and Pressure Ulcers Treatment Market, By Type of Wound, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- ConvaTec Group PLC
- Essity Aktiebolag AB
- ORGANOGENESIS HOLDINGS INC.
- Molnlycke Health Care AB
- Integra LifeSciences Holdings Corporation
- Smith and Nephew PLC.
- 3M Company
- B. Braun SE
- Cardinal Health Inc.
- Coloplast
- Company Profiles
- Analyst Views
- Future Outlook of the Market